The Francophone Foundation for Diabetes Research (FFRD) serves as the “armed wing” of the Francophone Diabetes Society (SFD) with the aim of promoting excellence in diabetes research, a common disease whose prevalence continues to rise. High-level and large-scale research is truly essential to get further insight into the mechanisms involved in the development of diabetes and its complications, as well as to improve their treatment and prevention.

Between its creation in 2013 up to 2024, the FFRD has supported 31 research projects led by teams of researchers from several Francophone countries, with a total funding amount of 8.3 million euros. A rigorous review by independent international experts is used to select projects funded by the FFRD. This ensures a choice of excellence and the prospect of significant advancements, both in fundamental and clinical research

The funding of this excellence in research by the FFRD is made possible thanks to our donor partners: the French Federation of Diabetics, and the laboratories Abbott, AstraZeneca, Lilly, Novo Nordisk, and Sanofi.

In the future, the FFRD aims to strengthen its visibility among healthcare professionals, people living with diabetes, and the general public through various initiatives. Furthermore, the FFRD will set a goal to expand its partnerships in order to continue and enhance its support for large-scale and excellent research.

Professor Bruno VERGÈS, President of FFRD